Imatinib Impurity 21 | CAS 110928-44-4 - Request Quote
Imatinib Impurity 21
| SZ CAT No: | SZ-I004054 |
| CAS No | 110928-44-4 |
| Mol.F. | C9H16O3 |
| Mol.Wt. | 172.2 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Imatinib Impurity 21 is chemically Methyl 4-(Hydroxymethyl)cyclohexanecarboxylate. Imatinib Impurity 21 is supplied with detailed characterization data compliant with regulatory guideline. Imatinib Impurity 21 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Imatinib.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 110928-44-4
Purchase 110928-44-4
Order 110928-44-4
Enquire 110928-44-4
price of 110928-44-4
110928-44-4 Supplier
110928-44-4 Manufacturer
110928-44-4 Exporter
buy high quality Imatinib Impurity 21
Purchase Imatinib Impurity 21
Imatinib Impurity 21 suppliers
Imatinib Impurity 21 manufacturers
Imatinib Impurity 21 price
Order Imatinib Impurity 21
Enquire Imatinib Impurity 21
Imatinib Impurity 21 cost
Imatinib Impurity 21 Supplier
Imatinib Impurity 21 Distributor
Imatinib Impurity 21 for Method Validation
Imatinib Reference Standard
Imatinib Impurity 21 for ANDA Filing
Imatinib Impurity 21 for Forced Degradation Studies
Imatinib Impurity 21 Identification Standards
Imatinib Impurity 21 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.


